针对后病毒性和相关类型的肺病,以米托基因激活蛋白激酶为指导的药物发现
Michael J Holtzman1,2,3, Yong Zhang4, Kangyun Wu4
1Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA mjholtzman@wustl.edu.
概括
病毒后肺部疾病在感染清除后引起重大疾病. 向小基激活蛋白激酶 (MAPK) 途径,特别是MAPK13,为慢性呼吸道疾病提供了新的药物开发机会.
科学领域:
- 肺部病理学 肺部病理学
- 病变的发生和发病.
- 药物发现 药物发现 药物发现
背景情况:
- 呼吸道病毒感染是一个主要的公共卫生问题,导致喘和COPD等慢性肺部疾病.
- 病毒后肺部疾病在感染后持续存在,导致显著的发病率和死亡率.
- 目前的治疗方法在修改这些持续的病毒后疾病过程方面缺乏精度.
研究的目的:
- 审查病毒后肺部疾病的发病机制,并确定关键的分子标.
- 突出介质激活蛋白激酶 (MAPK) 途径,特别是MAPK13,作为可用药物的标.
- 探索基于结构的药物设计,用于开发新型MAPK抑制剂.
主要方法:
- 目前关于病毒后肺病病因的文献综述.
- 识别和分析MAPK途径作为治疗点.
- 探索用于抑制剂开发的基于结构的药物设计原则.
主要成果:
- 线粒体激活蛋白激酶 (MAPK) 途径,特别是MAPK13,被确定在病毒后肺病的发病过程中至关重要.
- 基于结构的药物设计进步使得有针对性的MAPK抑制剂的开发成为可能.
- 这些抑制剂为抗病毒诱导的肺改造提供了新的治疗策略的潜力.
结论:
- 针对MAPK通路,特别是MAPK13,为治疗病毒后和相关慢性肺部疾病提供了一个有希望的策略.
- 药物设计的进步正在为新的临床候选人铺平道路.
- 这种方法针对不同的上皮和免疫细胞机制,提高了持续性肺部疾病的治疗疗效.
相关概念视频
01:07MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:26Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442